Company registration number 07974371 (England and Wales)
DSM PHARMA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
DSM PHARMA LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
DSM PHARMA LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
3
1,800,583
606,333
Tangible assets
4
1,191,967
2,861
2,992,550
609,194
Current assets
Stocks
65,793
54,790
Debtors
5
299,297
170,401
Cash at bank and in hand
25,327
257,329
390,417
482,520
Creditors: amounts falling due within one year
6
(1,192,279)
(310,803)
Net current (liabilities)/assets
(801,862)
171,717
Total assets less current liabilities
2,190,688
780,911
Creditors: amounts falling due after more than one year
7
(2,030,598)
(613,556)
Net assets
160,090
167,355
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
159,990
167,255
Total equity
160,090
167,355
DSM PHARMA LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2024
31 March 2024
- 2 -
For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 20 February 2025
Mrs Deepa Morar
Director
Company registration number 07974371 (England and Wales)
DSM PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -
1
Accounting policies
Company information
DSM Pharma Limited is a private company limited by shares incorporated in England and Wales. The registered office is 134 Buckingham Palace Road, London, SW1W 9SA.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.
1.3
Intangible fixed assets - goodwill
Acquired goodwill is written off in equal annual installments over its estimated useful economic life.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Land and buildings Freehold
Fixtures, fittings & equipment
20% Straight Line basis
Computer equipment
20% Straight Line basis.
1.5
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
10
6
DSM PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2023
1,155,000
Additions
1,402,500
At 31 March 2024
2,557,500
Amortisation and impairment
At 1 April 2023
548,667
Amortisation charged for the year
208,250
At 31 March 2024
756,917
Carrying amount
At 31 March 2024
1,800,583
At 31 March 2023
606,333
4
Tangible fixed assets
Land and buildings Freehold
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
£
Cost
At 1 April 2023
100,668
4,593
105,261
Additions
1,183,788
6,365
1,190,153
At 31 March 2024
1,183,788
100,668
10,958
1,295,414
Depreciation and impairment
At 1 April 2023
99,123
3,277
102,400
Depreciation charged in the year
386
661
1,047
At 31 March 2024
99,509
3,938
103,447
Carrying amount
At 31 March 2024
1,183,788
1,159
7,020
1,191,967
At 31 March 2023
1,545
1,316
2,861
DSM PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
238,733
127,607
Other debtors
56,416
38,646
Prepayments and accrued income
4,148
4,148
299,297
170,401
6
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
408,230
256,620
Corporation tax
30,000
27,858
Other taxation and social security
23,396
3,760
Other creditors
708,153
2,565
Accruals and deferred income
22,500
20,000
1,192,279
310,803
7
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Bank loans and overdrafts
2,030,598
613,556